Physician profile
David G Edelson
NPI 1568440485
$12,510.95
in general payments reported to CMS, 2019-2025
57 companies · $1,717 in 2025
The $1,717 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,394 · 2020: $1,477 · 2021: $1,852 · 2022: $1,458 · 2023: $1,821 · 2024: $1,792 · 2025: $1,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,289 · Education: $41.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,288.63 |
| Education | $41.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,336.36 | 2019-2025 | Otezla, Repatha, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,197.07 | 2019-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $932.02 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $870.89 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $865.95 | 2019-2025 | Wegovy, Ozempic, Saxenda |
| Abbvie INC. | $861.30 | 2019-2025 | Ubrelvy, Qulipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $780.65 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Pfizer INC. | $548.83 | 2019-2025 | |
| Antares Pharma, INC. | $545.98 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Takeda Pharmaceuticals U.S.A., INC. | $431.84 | 2019-2023 | Trintellix |
| Glaxosmithkline, LLC. | $361.50 | 2020-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Eisai INC. | $277.78 | 2019-2025 | |
| Merz North America, INC. | $260.06 | 2019-2021 | |
| Amarin Pharma, INC. | $243.45 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $206.84 | 2019-2023 | Delstrigo, Dificid |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $203.04 | 2019-2024 | Qsymia |
| Janssen Pharmaceuticals, INC | $198.35 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $184.98 | 2019-2025 | Veozah, Myrbetriq |
| Amneal Pharmaceuticals LLC | $148.76 | 2022-2023 | Unithroid |
| Abbott Laboratories | $140.19 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi Pasteur INC. | $128.14 | 2019-2024 | |
| Genzyme Corporation | $125.72 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $116.08 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $100.07 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $95.05 | 2019-2021 | |
| Azurity Pharmaceuticals, INC. | $92.91 | 2023-2024 | Edarbyclor, Edarbi, Edarbyclor |
| Halozyme INC | $87.47 | 2023 | |
| Baxter Healthcare | $84.91 | 2025 | Hillrom - Connex Spot Monitor |
| Currax Pharmaceuticals LLC | $82.37 | 2020-2021 | |
| Acerus Pharmaceuticals Corporation | $75.63 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $73.53 | 2019-2022 | |
| Ibsa Pharma INC. | $67.42 | 2022-2024 | Tirosint, Flector, Licart |
| Genentech USA, INC. | $66.72 | 2020-2021 | |
| Inspire Medical Systems, INC. | $63.85 | 2025 | Inspire |
| Arbor Pharmaceuticals, INC. | $58.21 | 2021-2022 | |
| Nalpropion Pharmaceuticals LLC | $51.93 | 2019 | |
| Philips North America LLC | $46.35 | 2021-2024 | (5044) Mcot |
| Allergan, INC. | $45.58 | 2020-2022 | |
| Corcept Therapeutics | $43.56 | 2025 | Korlym |
| Phadia US INC. | $43.01 | 2023-2024 | Immunocap |
| Renalytix Ai, INC. | $37.46 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Aytu Biopharma, INC. | $35.41 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $32.45 | 2023 | Quviviq |
| Dexcom, INC. | $27.77 | 2023 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $27.71 | 2020 | |
| Celgene Corporation | $24.13 | 2019 | |
| Redhill Biopharma INC. | $23.18 | 2022 | |
| Exact Sciences Corporation | $22.93 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $22.43 | 2025 | Gemtesa |
| Collegium Pharmaceutical, INC. | $21.83 | 2025 | Jornay Pm |
| Cleerly, INC. | $21.61 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Almatica Pharma LLC | $20.18 | 2021 | |
| Horizon Therapeutics Plc | $19.66 | 2020 | |
| Seqirus USA INC | $13.15 | 2019 | |
| Radius Health, INC. | $11.24 | 2019 | |
| Echosens North America, INC. | $4.40 | 2025 | Fibroscan |
| Linus Health, INC. | $1.06 | 2024 | Core Cognitive Evaluation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Edelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.